rs4143815
| Orientation | plus |
| Stabilized | plus |
| Make rs4143815(C;C) |
| Make rs4143815(C;G) |
| Make rs4143815(G;G) |
| Reference | GRCh37.p5 37.3/137 |
| Chromosome | 9 |
| Position | 5468257 |
| Gene | CD274, LOC107987045 |
| is a | snp |
| is | mentioned by |
| dbSNP | rs4143815 |
| dbSNP (classic) | rs4143815 |
| ClinGen | rs4143815 |
| ebi | rs4143815 |
| HLI | rs4143815 |
| Exac | rs4143815 |
| Gnomad | rs4143815 |
| Varsome | rs4143815 |
| LitVar | rs4143815 |
| Map | rs4143815 |
| PheGenI | rs4143815 |
| Biobank | rs4143815 |
| 1000 genomes | rs4143815 |
| hgdp | rs4143815 |
| ensembl | rs4143815 |
| geneview | rs4143815 |
| scholar | rs4143815 |
| rs4143815 | |
| pharmgkb | rs4143815 |
| gwascentral | rs4143815 |
| openSNP | rs4143815 |
| 23andMe | rs4143815 |
| SNPshot | rs4143815 |
| SNPdbe | rs4143815 |
| MSV3d | rs4143815 |
| GWAS Ctlg | rs4143815 |
| GMAF | 0.332 |
| Max Magnitude | 0 |
| ? | (C;C) (C;G) (G;G) | 28 |
|---|---|---|
|
| ||
rs2282055 and rs4143815 may be biomarkers for the efficacy of nivolumab. [PMID 28332580
]
[PMID 23430453] A miR-570 binding site polymorphism in the B7-H1 gene is associated with the risk of gastric adenocarcinoma
[PMID 28677815
] Variant SNPs at the microRNA complementary site in the B7‑H1 3'‑untranslated region increase the risk of non‑small cell lung cancer.
[PMID 29060926] Programmed death-1 lignd-1 gene rs2890658 polymorphism associated with the risk of esophageal squamous cell carcinoma in smokers.
[PMID 29940275] Correlations of PD-L1 gene polymorphisms with susceptibility and prognosis in hepatocellular carcinoma in a Chinese Han population.
[PMID 30534571
] Association of PD-1 and PD-L1 Genetic Polymorphyisms with Type 1 Diabetes Susceptibility.
[PMID 30552042] Association of PD-L1 gene rs4143815 C>G polymorphism and human cancer susceptibility: A systematic review and meta-analysis.
[PMID 30594267
] Association of a PD-L2 Gene Polymorphism with Chronic Lymphatic Filariasis in a South Indian Cohort.
[PMID 33255938
] SNP-SNP Interaction in Genes Encoding PD-1/PD-L1 Axis as a Potential Risk Factor for Clear Cell Renal Cell Carcinoma.
